Conference Coverage: SABCS 2023
Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment
December 12, 2023
FACULTY CHAIR
Adam Brufsky, MD, PhD
University of Pittsburgh School of Medicine, PA, USA
Faculty Members
Mark Pegram, MD
Stanford University School of Medicine, Stanford, CA, USA
Joyce A. O’Shaughnessy, MD
Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX, USA
William Sikov, MD, FACP, FNCBC
Women & Infants Hospital of Rhode Island, Providence, RI, USA
Guy Jerusalem, MD, PhD
Sart-Tillman University Hospital, Liège, Belgium
Giuseppe Curigliano, MD, PhD
Istituto Europeo di Oncologia, Milan, Italy
Javier Cortes, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain
REPORT TOPICS INCLUDE
- New and Emerging Treatments in HER2+ Early and Metastatic BC
- New and Emerging Approaches in HR+, HER2– Early BC
- New and Emerging Approaches in HR+, HER2– Metastatic BC
- Advances in Early and Metastatic Triple-Negative Breast Cancer (TNBC)
